GCKR and metabolic dysfunction-associated steatotic liver disease: We confirmed the association of rs780094 in GCKR with NAFLD in a case/control analysis but at a much weaker level (p = 0.011, OR = 0.82, 95%CI: 0.70–0.95) than that shown for the populations of European-descent.